Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope

While it has been established that peptides modeling the C-helical region of human immunodeficiency virus type 1 gp41 are potent in vivo inhibitors of virus replication, their mechanism of action has yet to be determined. It has been proposed, but never directly demonstrated, that these peptides blo...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

I whakaputaina i:	J Virol
Ngā kaituhi matua:	Kilgore, Nicole R., Salzwedel, Karl, Reddick, Mary, Allaway, Graham P., Wild, Carl T.
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	American Society for Microbiology (ASM) 2003
Ngā marau:	Vaccines and Antiviral Agents
Urunga tuihono:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164814/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12805467/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.13.7669-7672.2003
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!